EXCITATORY AMINO ACID REGULATION OF VASOPRESSIN CELLS

加压素细胞的兴奋性氨基酸调节

基本信息

  • 批准号:
    2262533
  • 负责人:
  • 金额:
    $ 19.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1977
  • 资助国家:
    美国
  • 起止时间:
    1977-07-01 至 1996-12-31
  • 项目状态:
    已结题

项目摘要

Our studies will focus on the chemical and physiological factors which control the secretion of vasopressin by magnocellular neurons in the hypothalamic supraoptic nucleus. These factors will be identified, characterized and an attempt will be made to relate these to the osmotic regulation of vasopressin secretion. The use of an in vitro approach with the hypothalamo-neurohypophysial complex (HNC) will give the degree of control necessary to achieve these goals. The HNC contains the entire supraoptic-neuroendocrine final common pathway including the two intact supraoptic nuclei (NSO), the supraoptico-neurohypophysial tract (SOHT) and the neurosecretory terminals of the neural lobe (NL). Every major site suspected of being involved in the osmotic regulation of vasopressin secretion is present in the HNC. The HNC explant retains osmosensitivity in vitro and can approach in vivo responsiveness. Thus, the entire functional pathway is present for the exploration of the functional integration of osmotic stimuli and the transduction of this information at the level of the supraoptic nucleus. We will characterize the release of vasopressin and establish the conditions which allow precise temporal and semi-quantitative analys of responsiveness via the SOHT. Effects of chemical and osmotic stimuli and their interactions will be characterized and will include screening for the effects of various putative neurotransmitters on the release of vasopressin (cholinergic, angiotensin II, norepinephrine, enkephalin, dopamine). In particular, we will focus on the specific contribution of the NSO with particular emphasis on the nicotinic cholinergic system which has been strongly implicated in the control of vasopressin secretion. The localization of putative nicotinic receptors on vasopressin-containing magnocellular neurons in NSO will be examined. Parallel experiments will be run to assess specific properties of these receptors which may contribute to osmotic sensitivity of the NSO. Investigation of the electrophysiological properties of identified cells in the NSO during chemical and osmotic challenges will provide detailed temporal comparison of the physiological responses with the release of vasopressin. Concomitant double- and triple-labeling procedures on dye-marked neurons will be used for cytoarchitectonic reconstruction and electron microscopic analysis of synaptic inputs on immunocytochemically-identified neurons in the NSO. Thus, the HNC explant represents a simple, viable, highly controlled mammalian neural system in which unknown physiological processes express their effects on a well defined final pathway. Ideal neuroendocrine control system.
我们的研究将集中在化学和生理因素

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICK B MEEKER其他文献

RICK B MEEKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICK B MEEKER', 18)}}的其他基金

Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
研究确定 LM11A-31 作为神经保护剂对老年艾滋病毒感染者和抗逆转录病毒治疗神经认知障碍患者的安全性、耐受性和可行性
  • 批准号:
    10762833
  • 财政年份:
    2023
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
  • 批准号:
    10204135
  • 财政年份:
    2018
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
  • 批准号:
    9975935
  • 财政年份:
    2018
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
  • 批准号:
    9751991
  • 财政年份:
    2018
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
  • 批准号:
    10448257
  • 财政年份:
    2018
  • 资助金额:
    $ 19.82万
  • 项目类别:
A degradomics strategy for the analysis of inflammation-associated neuronal vulnerability
分析炎症相关神经元脆弱性的降解组学策略
  • 批准号:
    9374952
  • 财政年份:
    2017
  • 资助金额:
    $ 19.82万
  • 项目类别:
LM11A-31 neuroprotective efficacy in an animal model of HIV
LM11A-31 在 HIV 动物模型中的神经保护功效
  • 批准号:
    8896088
  • 财政年份:
    2014
  • 资助金额:
    $ 19.82万
  • 项目类别:
LM11A-31 neuroprotective efficacy in an animal model of HIV
LM11A-31 在 HIV 动物模型中的神经保护功效
  • 批准号:
    8789501
  • 财政年份:
    2014
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neurotrophin Protection in HIV and Aging
神经营养素对艾滋病毒和衰老的保护作用
  • 批准号:
    8525780
  • 财政年份:
    2013
  • 资助金额:
    $ 19.82万
  • 项目类别:
Neurotrophin Protection in HIV and Aging
神经营养素对艾滋病毒和衰老的保护作用
  • 批准号:
    8805857
  • 财政年份:
    2013
  • 资助金额:
    $ 19.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了